Annalisa Antonini
Overview
Explore the profile of Annalisa Antonini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
493
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Baldari S, Antonini A, Di Rocco G, Toietta G
Cancer Innov
. 2024 Dec;
4(1):e149.
PMID: 39640071
Background: The incidence of alcohol-associated cancers is higher within Asian populations having an increased prevalence of an inactivating mutation in aldehyde dehydrogenase 2 (), a mitochondrial enzyme required for the...
2.
Di Nardo M, Astigiano S, Baldari S, Pallotta M, Porta G, Pigozzi S, et al.
J Exp Clin Cancer Res
. 2024 Feb;
43(1):49.
PMID: 38365745
Background: SMC1A is a subunit of the cohesin complex that participates in many DNA- and chromosome-related biological processes. Previous studies have established that SMC1A is involved in cancer development and...
3.
Carlomosti F, DAgostino M, Beji S, Torcinaro A, Rizzi R, Zaccagnini G, et al.
Antioxid Redox Signal
. 2016 Dec;
27(6):328-344.
PMID: 27960536
Aims: Reactive oxygen species (ROS) play a pivotal role in different pathologic conditions, including ischemia, diabetes, and aging. We previously showed that ROS enhance miR-200c expression, causing endothelial cell (EC)...
4.
DArcangelo D, Facchiano F, Nassa G, Stancato A, Antonini A, Rossi S, et al.
Oncotarget
. 2016 Oct;
7(47):77257-77275.
PMID: 27764787
Melanoma is the most aggressive skin-cancer, showing high mortality at advanced stages. Platelet Derived Growth Factor Receptor-alpha (PDGFR-alpha) potently inhibits melanoma- and endothelium-proliferation and its expression is significantly reduced in...
5.
Cicchillitti L, Stefano V, Isaia E, Crimaldi L, Fasanaro P, Ambrosino V, et al.
J Biol Chem
. 2012 Nov;
287(53):44761-71.
PMID: 23148210
MicroRNA-210 (miR-210) induction is a virtually constant feature of the hypoxic response in both normal and transformed cells, regulating several key aspects of cardiovascular diseases and cancer. We found that...
6.
Di Rocco G, Gentile A, Antonini A, Truffa S, Piaggio G, Capogrossi M, et al.
Cell Transplant
. 2012 Apr;
21(9):1997-2008.
PMID: 22469297
Presently, orthotopic liver transplant is the major therapeutic option for patients affected by primary liver diseases. This procedure is characterized by major invasive surgery, scarcity of donor organs, high costs,...
7.
Di Rocco G, Gentile A, Antonini A, Ceradini F, Wu J, Capogrossi M, et al.
Stem Cells Int
. 2011 Jan;
2011:304562.
PMID: 21234108
Chronic ulcers represent a major health problem in diabetic patients resulting in pain and discomfort. Conventional therapy does not guarantee adequate wound repair. In diabetes, impaired healing is partly due...
8.
Rosati J, Spallotta F, Nanni S, Grasselli A, Antonini A, Vincenti S, et al.
Arterioscler Thromb Vasc Biol
. 2011 Jan;
31(4):898-907.
PMID: 21233447
Objective: Smad-interacting protein-1 (Sip1/ZEB2) is a transcriptional repressor of the telomerase reverse transcriptase catalytic subunit (Tert) and has recently been identified as a key regulator of embryonic cell fate with...
9.
Gurtner A, Fuschi P, Martelli F, Manni I, Artuso S, Simonte G, et al.
Cancer Res
. 2010 Oct;
70(23):9711-20.
PMID: 20952509
The CCAAT-binding transcription factor NF-Y plays a central role in regulating cellular proliferation by controlling the expression of genes required for cell-cycle progression such as cyclin A, cyclin B1, cyclin...
10.
Panieri E, Toietta G, Mele M, Labate V, Chiatamone Ranieri S, Fusco S, et al.
Aging (Albany NY)
. 2010 Aug;
2(8):487-503.
PMID: 20739737
Deregulated nutrient signaling plays pivotal roles in body ageing and in diabetic complications; biochemical cascades linking energy dysmetabolism to cell damage and loss are still incompletely clarified, and novel molecular...